Pfizer

As we enter the second month of the new school year and given the high number of COVID-19 cases, many reasonable questions arise regarding the protection of our children against COVID-19.

Two Turkish-German scientists were awarded Greece's Empress Theophano Prize on Oct. 13 for saving millions of lives with the development of the first vaccine against the coronavirus, according to the Empress Theophano Foundation. 

Inauguration of the Pfizer Digital Innovation Center

Ljubljana – Slovenia will follow the recommendation of the national advisory committee on immunisation to use the Pfizer vaccine for those under 30 years old, Health Minister Janez Poklukar said on Monday. In general, the use of mRNA vaccines will be recommended over viral vector vaccines.

Mobile Vaccination Site Avilble at Sofia Airport as of 11 October   

From Monday, October 11, a specially equipped mobile vaccination bus will be deployed at Terminal 1 of Sofia airport , in front of the building of "Arrivals".

Iceland on Oct. 8 suspended the Moderna anti-Covid vaccine, citing the slight increased risks of cardiac inflammation, going further than its Nordic neighbors which simply limited use of the jabs.

Fully vaccinated travelers from dozens of more countries, including Turkey, will not be required to self-isolate in the U.K. starting next week, the British government has announced.

He attended the opening of the NCR campus in Belgrade.
"Nobody noticed that because they mix things up. Monday must always be compared to Monday, not another day. We have two days of decreased percentage in absolute numbers. Today is the second day, the next morning we have a reduction in the number of infected.

Vaccination with two doses of the Pfizer jab stays highly effective against severe COVID - including the Delta variant - for at least six months, an analysis of U.S. patients said on Oct. 4.

While previous data from clinical trials have shown jabs protect against hospitalization, the study published in the Lancet measures one vaccine's effectiveness over time in a real-world setting.

A new formulation is likely to be needed by the middle of next year to protect against COVID-19 as it mutates, Uğur Şahin, the chief executive of BioNTech that is behind one of the first mRNA vaccines against the coronavirus, has told the Financial Times.

The Germany-based BioNTech developed the COVID-19 vaccine jointly with the U.S. pharmaceutical company Pfizer.